25 research outputs found
Catatonia Associated with Initiating Paliperidone Treatment
Get PDFWe present a case of catatonia, which occurred shortly after starting a new antipsychotic, paliperidone, an active metabolite of risperidone. Catatonia may be caused by a variety of conditions, including metabolic, neurologic, psychiatric and toxic processes. Interestingly, risperidone, which has been thought to cause several cases of catatonia, has also been recommended as a potential treatment. We discuss potential mechanisms for causes of drug-induced catatonia as well as potential treatment options
Exposures through Breastmilk: An Analysis of Exposure and Information Calls to US Poison Centers, 2001-2017
Get PDFImpact of Legalizing Recreational Cannabis Sales on Cannabis Exposure Calls to Poison Centers 2008-2017
Get PDFSex Differences in Pediatric Exploratory Exposures: A Retrospective Review of National Poison Data System (NPDS) Exposures 2007-2016
Get PDFSex Differences in Adverse Drug Reactions and Adverse Drug Events in Older Adults: A Retrospective Review of National Poison Data System Cases 2007-2016.
Get PDFSex Differences in Intentional Exposures among Adolescents and Adults: A Retrospective Review of National Poison Data System (NPDS) Pharmaceutical Exposures 2007-2016
Get PDFRecommended from our members
Catatonia Associated with Initiating Paliperidone Treatment
No full textWe present a case of catatonia, which occurred shortly after starting a new antipsychotic, paliperidone, an active metabolite of risperidone. Catatonia may be caused by a variety of conditions, including metabolic, neurologic, psychiatric and toxic processes. Interestingly, risperidone, which has been thought to cause several cases of catatonia, has also been recommended as a potential treatment. We discuss potential mechanisms for causes of drug-induced catatonia as well as potential treatment options. [West J Emerg Med. 2010; 11(2):186-188.
